Anuj Madhok

Anuj Madhok has a wealth of experience in the pharmaceutical and banking industries. Anuj is currently Chief Business Officer at Transine Therapeutics, Founder of Novalio Pharma Limited, and Head of Business Development at Cytoki Pharma, all since 2021. Prior to this, they were Chief Executive Officer at Zarodex Therapeutics (2020), Chief Business Officer at Topivert Pharma Limited (2018), VP Business Development at Jazz Pharmaceuticals (2012), VP Corporate Development & Member of Executive Committee at EUSA Pharma (2009), Associate at JPMorgan (2008), Associate at HSBC Bank Plc (2005), and Associate at Bear Stearns & Co. (2003).

Anuj Madhok obtained their Danish A-levels from Marie Kruses Skole in 1990-1993. Anuj then went on to pursue a B.Sc. in Chemistry from Københavns Universitet - University of Copenhagen from 1993-1996. Finally, they completed their PhD in Chemical Engineering from the University of Cambridge in 1997-2001.